NEW YORK (GenomeWeb News) – Seattle-based angel funding group Alliance of Angels said today that medical genomics startup ActX raised $1.9 million in a seed round.

Alliance of Angels led the round. According to the angel investment group, ActX is " focused on making actionable patient genomic information truly useful in everyday medical practice."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The president of France's National Research Agency has resigned, according to Nature News.

A senator wants a "right-to-try" provision in the US Food and Drug Administration funding bill, but an ethicist says at Stat News that it would undermine the role of clinical trials.

The Guardian's Barbara Ellen has tried out some DNA testing services to see whether they provide valuable information.

In PNAS this week: red algae Porphyra umbicalis genome, deep neural network model for sequencing peptides, and more.